The MHRA has executed a significant operation, seizing a staggering 7.7 million doses of illegal medicines and eliminating hundreds of illicit online listings.
Cardiff University spin-out Draig Therapeutics has been awarded £107m ($140m) to advance the development of novel therapies for major neuropsychiatric disorders.
A revolutionary STI test developed by UK-based Linear Diagnostics, a University of Birmingham spin-out company, delivers lab-accurate results in five minutes.
An 'AI scientist', working in collaboration with human scientists, has discovered that combinations of cheap and safe drugs could be effective at treating breast cancer.
In a groundbreaking first, psilocybin is entering gastroenterology. Dr. Erin Mauney leads a pioneering study exploring how psychedelic therapy could transform treatment for millions suffering from treatment-resistant Irritable Bowel Syndrome, offering new hope for gut-brain disorders.
Jacqueline Alvarez, Chief of the Chemicals and Health Branch at the UN Environment Programme (UNEP), explores the importance of holistic, One Health efforts to mitigate the growing threat of antimicrobial resistance.
Most medication errors are preventable with the right conditions. Successful technology implementation requires careful planning, proper training, and a commitment to system-wide improvements, as explained by Stéphane Boulanger, Policy Advisor at the European Patient Safety Foundation (EUPSF).
A new study by the University of Manchester has found that a new clotbusting drug is significantly better at treating ischemic stroke than existing treatments.
An innovative fridge-free vaccine will enter its first-in-human clinical trial at the National Institute for Health and Care Research (NIHR) Southampton Clinical Research Facility.